Is immunotherapy-induced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity?
Research output: Contribution to journal › Journal article › Research › peer-review
The role of IgG4 during allergen-specific immunotherapy (SIT) is still controversial. The available studies present paramount differences in in vitro techniques, allergens, and clinical outcome parameters. By implementing a sensitive method, and pivotal clinical outcome parameters, we wanted to ascertain the utility of IgG4 as a clinical marker of decreased allergen-specific sensitivity to a common aeroallergen.
Original language | English |
---|---|
Journal | International Archives of Allergy and Immunology |
Volume | 136 |
Issue number | 4 |
Pages (from-to) | 340-6 |
Number of pages | 7 |
ISSN | 1018-2438 |
DOIs | |
Publication status | Published - 2005 |
- Betula, Biological Markers, Humans, Hypersensitivity, Immunoglobulin E, Immunoglobulin G, Pollen
Research areas
ID: 43536135